Using advanced algorithms to analyze viral genomes for better control of COVID-19
Fast and flexible Bayesian phylogenetics via modern machine learning
This study is all about finding better ways to analyze the genetic information of the SARS-CoV-2 virus, which causes COVID-19, so we can understand how it spreads and figure out better ways to control it, using advanced techniques to look at lots of data quickly and accurately.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10873937 on NIH RePORTER |
What this research studies
This research focuses on improving the analysis of viral genomes, particularly those of SARS-CoV-2, to better understand how the virus spreads and how it can be controlled. By employing a novel Bayesian variational inference approach, the team aims to analyze thousands of viral genomes quickly and accurately. This method will integrate complex data, such as migration patterns and sampling locations, into the phylogenetic analysis, potentially leading to more effective strategies for managing viral outbreaks. The research will also develop new theoretical frameworks and algorithms to ensure reliable results.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals affected by COVID-19 or those involved in managing viral outbreaks.
Not a fit: Patients who are not affected by viral infections or those who do not have a role in public health management may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for controlling COVID-19 and similar viral outbreaks.
How similar studies have performed: Other research has shown promise in using advanced computational methods for viral genome analysis, indicating that this approach could be successful.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Matsen, Frederick Albert — Fred Hutchinson Cancer Center
- Study coordinator: Matsen, Frederick Albert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.